COMMUNIQUÉS West-GlobeNewswire

Kiadis Pharma announces two senior management appointments
06/09/2018
Kiadis Pharma announces two senior management appointments Strengthens Senior Management Team with Chief Human Resources Officer and General Counsel and Company Secretary Amsterdam, The Netherlands, September 6, 2018 - [...]
argenx doses first patient in global Phase 3 registration trial of efgartigimod for the treatment of generalized myasthenia gravis
06/09/2018
September 6, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo
06/09/2018
Novartis to focus Sandoz division in US on higher growth areas and will sell selected portions of the Sandoz US portfolio to Aurobindo Pharma USA Inc. Agreement comprises the Sandoz US generic oral solids and Sandoz US [...]
Retrophin Prices Upsized $240 Million Convertible Senior Notes Offering
06/09/2018
SAN DIEGO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the pricing of its offering of $240 million aggregate principal amount of 2.50% convertible senior notes due 2025 (the “notes [...]
Phase 2 Clinical Trial for Venous Leg Ulcers Nears Completion
06/09/2018
BRISBANE, Australia, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Factor Therapeutics Limited (ASX: FTT, the “Company”), an Australian biomedical company developing therapeutics for advanced wound care, is pleased to announce [...]
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ:PTLA) announced today that on August 31, 2018, the Compensation Committee of the Board of Directors approved, [...]
Fluidigm to Participate at Upcoming Investor Events in September
06/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s management team will [...]
BeiGene to Present Data on Anti-PD-1 Antibody Tislelizumab at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto
05/09/2018
CAMBRIDGE, Mass. and BEIJING, China, Sept. 05, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Avivagen Announces Q3 Financial Results and Proposed Extension of Warrants
05/09/2018
OTTAWA, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2018
05/09/2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers ERN France, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Monthly information related to total number of voting rights and shares composing the share [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 août 2018
05/09/2018
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers ERN France, 05 sept. 2018 (GLOBE NEWSWIRE) -- Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital [...]
EyePoint Pharmaceuticals Secures Pass-through Payment Status and Assignment of C-Code for DEXYCU™
05/09/2018
WATERTOWN, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Veritas Welcomes Exclusive Marketing Agreement Between 3 Carbon Extractions and ExtractionTek Solutions
05/09/2018
VANCOUVER, British Columbia, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that its subsidiary, 3 Carbon [...]
Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue
05/09/2018
Fiscal Year 2018 Revenue Rises 35% to $36.7 Million FARMINGDALE, N.Y., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic [...]
Predictive Technology Group Announces Updated Presentation Time at the H.C. Wainwright 20th Annual Global Investment Conference
05/09/2018
Presentation and webcast to begin September 6 at 3:50 p.m. Eastern Time SALT LAKE CITY, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
05/09/2018
TUSTIN, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/09/2018
WAYNE, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Nuvectra to Participate in Two Upcoming Investor Conferences
05/09/2018
PLANO, Texas, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Adoption grows for Allscripts cutting edge Prescription Price Transparency Solution
05/09/2018
Incorporates real-time price data into prescribing workflow CHICAGO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, is delivering comprehensive [...]

Pages